Literature DB >> 19868294

STANDARDIZATION OF ANTIMENINGOCOCCIC SERUM.

H L Amoss1, P Marsh.   

Abstract

Experiments were made for the purpose of testing the reaction of protection against infection as a measure of potency of antimeningococcic serum. The results of the experiments were extremely variable and bore no relation to the quality of the sera as determined by the period of immunization of the horses from which they were obtained, or the indications of efficiency based upon their employment in human cases of epidemic meningitis. The results also failed entirely to conform to the agglutination titer of the sera tested and to be affected by the different type forms of the meningococci. We regard the protective power for laboratory animals of the antimeningococcic serum as an unsuitable index of its value in human medicine and as inferior to the agglutination titer as a standard of potency.

Entities:  

Year:  1918        PMID: 19868294      PMCID: PMC2126311          DOI: 10.1084/jem.28.6.779

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS.

Authors:  S Flexner
Journal:  J Exp Med       Date:  1907-03-14       Impact factor: 14.307

2.  STANDARDIZATION OF THE ANTIMENINGITIS SERUM.

Authors:  J W Jobling
Journal:  J Exp Med       Date:  1909-07-17       Impact factor: 14.307

3.  CHEMICAL VERSUS SERUM TREATMENT OF EPIDEMIC MENINGITIS.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1916-05-01       Impact factor: 14.307

4.  CONTRIBUTIONS TO THE BIOLOGY OF DIPLOCOCCUS INTRACELLULARIS.

Authors:  S Flexner
Journal:  J Exp Med       Date:  1907-03-14       Impact factor: 14.307

5.  A METHOD FOR THE RAPID PREPARATION OF ANTIMENINGITIS SERUM.

Authors:  H L Amoss; M Wollstein
Journal:  J Exp Med       Date:  1916-03-01       Impact factor: 14.307

  5 in total
  1 in total

1.  [Not Available].

Authors: 
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.